MALIN LIFE SCIENCES HOLDINGS LTD purchased 22.2% of their position (2.15M shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $7.53M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/10/2022ACC: 0001104659-22-088886
10% Owner
Since Jul 2020
+2.15M
Net shares
Net buyer
$7.53M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.15M acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+2.15M
Price / share
$3.50
Trade value
$7.53M
% of position
22.2%
8/8/2022
9.69M→11.84M
Total
Net shares
+2.15M
Net value
$7.53M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 8/8/2022 | P · Purchase | +2.15M | $3.50 | $7.53M | 22.2% | 9.69M | 11.84M |
| Total | +2.15M | $7.53M | ||||||
Derivative Transactions0
No derivative transactions reported